XBiotech (XBIT) Return on Sales by Net Profit

XBIT (xbiotech.com) - company brandmark

XBiotech Inc. (XBIT) develops human antibodies to combat tumors, protecting its niche through patents. The operating net profit margin reflects the dynamics of this process, where 0.00 determines the current value of the metric. However, fierce competition with pharma behemoths regarding therapy efficacy and the risks associated with a narrow development portfolio make the company's financial stability dependent on clinical trial outcomes.

xbiotech.com (XBIT) - Net Margin from 07/04/2022 to 11/19/2026

XBiotech Inc (XBIT) - metric breakdowns and financial figures

- market value and analyst target forecast:
Summary company analytics:XBiotech - XBIT
Flagship merchandise of XBiotech

XBiotech Inc. is conducting capital-intensive antibody development amidst fierce competition with global pharma behemoths. Net margin measures the portion of profit from every dollar of revenue after deducting all operating and financial expenses. The trend in net margin reflects the speed at which management adapts to market shocks. Sharp declines in this indicator may signal excessive R&D spending or competitive pressure. A stable metric level confirms the fundamental resilience of capital against pessimistic scenarios.

Competitors of XBiotech Inc. (XBIT)

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|CVM (CEL-SCI Corporation) - Company Net Profitability|Net Sales Margin OSTX|Net Sales Margin Radiopharm Theranostics Ltd (RADX)|Net Sales Margin ARTV (Artiva Biotherapeutics)|Net Sales Margin Adlai Nortye Ltd. ANL|Veru Inc - Net Sales Margin|Company Sales Margin Tempest Therapeutics TPST|XLO: Net Sales Margin|Enochian BioSciences (RENB) - Net Sales Margin|Return on Sales by Net Profit MURA|Kairos Pharma Ltd - Net Profit Margin|Net Sales Margin OKUR|CytoMed Therapeutics Limited (GDTC) - Net Profitability Margin|Net Sales Margin CRIS (Curis, Inc.)|APLM: Net Return on Sales|Tharimmune Corporation - Net Sales Margin|ADVB: Net Margin|GNPX: Net Sales Margin|CLDI (Calidi Biotherapeutics Inc.) - Net Margin|Net Margin Sunshine Biopharma, Inc.|Net Sales Margin xeneticbio.com|Net Margin Salarius (SLRX)|Return on Sales by Net Profit Purple Biotech PPBT|Net Margin American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Net Margin|Checkpoint Therapeutics Inc. - Net Sales Margin|Net Profit Rate ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Return on Sales by Net Profit|Ikena Oncology, Inc. - Net Profit Rate|Return on Sales by Net Profit NTBL|VIRX: Net Profit Rate|Net Margin MorphoSys Corporation (MOR)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)